000 | 01909 a2200541 4500 | ||
---|---|---|---|
005 | 20250517074029.0 | ||
264 | 0 | _c20170516 | |
008 | 201705s 0 0 eng d | ||
022 | _a1097-6809 | ||
024 | 7 |
_a10.1016/j.jvs.2015.10.010 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTang, Bo | |
245 | 0 | 0 |
_aHydrogen sulfide ameliorates acute lung injury induced by infrarenal aortic cross-clamping by inhibiting inflammation and angiopoietin 2 release. _h[electronic resource] |
260 |
_bJournal of vascular surgery _c02 2017 |
||
300 |
_a501-508.e1 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAcute Lung Injury _xetiology |
650 | 0 | 4 |
_aAlkynes _xpharmacology |
650 | 0 | 4 |
_aAngiopoietin-2 _xmetabolism |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-Inflammatory Agents _xmetabolism |
650 | 0 | 4 |
_aAorta, Abdominal _xsurgery |
650 | 0 | 4 | _aConstriction |
650 | 0 | 4 |
_aCystathionine gamma-Lyase _xantagonists & inhibitors |
650 | 0 | 4 | _aCytoprotection |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aDown-Regulation |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 |
_aGlycine _xanalogs & derivatives |
650 | 0 | 4 |
_aHydrogen Sulfide _xmetabolism |
650 | 0 | 4 |
_aLung _xdrug effects |
650 | 0 | 4 |
_aLyases _xmetabolism |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMorpholines _xmetabolism |
650 | 0 | 4 |
_aOrganothiophosphorus Compounds _xmetabolism |
650 | 0 | 4 |
_aPneumonia _xetiology |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-akt _xmetabolism |
650 | 0 | 4 | _aRats, Wistar |
700 | 1 | _aMa, Lan | |
700 | 1 | _aYao, Xiaoyi | |
700 | 1 | _aTan, Gang | |
700 | 1 | _aHan, Peng | |
700 | 1 | _aYu, Tianchi | |
700 | 1 | _aLiu, Bing | |
700 | 1 | _aSun, Xueying | |
773 | 0 |
_tJournal of vascular surgery _gvol. 65 _gno. 2 _gp. 501-508.e1 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jvs.2015.10.010 _zAvailable from publisher's website |
999 |
_c25643049 _d25643049 |